FLT3 and acute myeloid leukemia: The prognosis of AML is also determined by the type of genetic mutation, and AML with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, which is a receptor-type tyrosine kinase, is known to have a poor prognosis [1].